1,3-Dibromo-5-chloro-2-iodo-benzene, 98+%, 500mg

2-(((tert-Butyldimethylsilyl)oxy)methyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 95.0%, 100mg

5-Bromo-2-chloroethylbenzene, 95.0%, 10g

(4-Aminopiperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone, 95%, 500mg

Colonne HPLC NUCLEODUR® 300-5 C4 ec, 150 mm, 4 mm, 1 pièce(s)

8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione, 95.0%, 25g

7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 5g

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride, 95.0%, 25g

2-Chloro-1,3-bis(methoxycarbonyl)guanidine, 95.0%, 25g

(2S)-2-Amino-2,3-dimethylbutanoic acid, 95.0%, 5g

7-Cyano-1H-indole-3-carboxylic acid, 97%, 5g

2-[(2-methylbutanoyl)amino]benzoic acid, 95.0%, 5g

2-AZASPIRO[4.5]DECANE-3,8-DIONE, 95.0%, 250mg